Scandinavian journal of gastroenterology. Supplement最新文献

{"title":"Abstract from the 41st Nordic Gastroenterology Congress, 8-11 June 2010, Copenhagen, Denmark.","authors":"","doi":"10.3109/00365521.2010.503379","DOIUrl":"https://doi.org/10.3109/00365521.2010.503379","url":null,"abstract":"Book List of content Invited Speaker Abstracts 28 Free paper abstracts 45 Nurse programme invited speaker abstracts 61 Nurse programme oral presentation abstracts 64 Poster presentation abstracts 66 Postgraduate course abstracts 87 Session Chair abstracts 90 Author Index 91 Invited Speaker abstracts Interventional oncology in liver metastases Sat 1 Vogl, Thomas University Hospital of Frankfurt, Frankfurt, Germany Minimal-invasive therapies for tumor treatment in solid organs like liver or lung are based on different intravascular techniques (e.g. transarterial chemoembolization (TACE)) or thermal techniques (e.g. laser-induced thermotherapy (LITT)). In contrast to systemic chemotherapy local chemotherapy can be injected in the tumor area in a concentration up to 100 times higher with fewer side effects. Besides, selective ischemia and tumor starvation are caused by embolizing the branches of the hepatic artery. Under local anaesthesia the femoral artery is punctured in the inguinal region followed by insertion of a femoral sheath. The latter allows free exchange of catheters without vessel wall injury while bleeding is prevented. After identifying the hepatic artery the catheter is advanced into the aorta. A small catheter is passed through the hepatic artery into the tumor-supplying artery and chemoembolization is locally injected in the tumor followed by an embolizing material. After removing catheters/sheath, a small suture is prepared to prevent bleeding at the puncture site. The patient is then observed for 4-6h during which complications can be diagnosed and treated. To monitor treatment success and rule out complications, unenhanced CT is performed post procedure. Typically 2-3 TACE sessions in 4-week intervals are necessary. Tumor response is determined 4 weeks later by MRI. LITT is a minimal-invasive technique for local tumor destruction in solid organs using laser light. The laser (Nd:YAG laser (1,064nm)) is exactly targeted on the tissue volume. Due to the comparably high penetrability of photons and complication-free transfer of energy through guide-light, laser of near-infrared region (NIR) is used. The energy is applied to the target tissue using special laser applicators. Laser light energy is absorbed, which causes heating and thus coagulation of the tumor tissue. To benefi t from the advantages of the effect and accuracy of the therapy, all factors contributing to the therapy success must be fi ne-tuned by calculating duration and output of the laser. Depending on size, number and location of the lesion more laser applicators and more cycles of therapy may be required. In practice a temperature of about 60-110°C is achieved in the tumor tissue. Challenges in combating the obesity epidemic Inv 01 Sorensen, Thorkild IA Bispebjerg University Hospital, Institute of Preventive Medicine, Copenhagen, Denmark Background: An obesity epidemic has developed worldwide, even in less developed and poor countries. The epidemic creates a new ser","PeriodicalId":21517,"journal":{"name":"Scandinavian journal of gastroenterology. Supplement","volume":" 247","pages":"28-90"},"PeriodicalIF":0.0,"publicationDate":"2010-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3109/00365521.2010.503379","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29100963","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"History of Helicobacter infection.","authors":"S. Rune","doi":"10.3109/00365529609094505","DOIUrl":"https://doi.org/10.3109/00365529609094505","url":null,"abstract":"Helicobacter pylori infection is now recognized as the cause of most cases of chronic gastritis, and a major causal factor in peptic ulcer disease. However, though the presence of intragastric bacteria has been recognized for many years, the connection between H. pylori and peptic ulcers has only been established during the last decade. Pathological studies have suggested that intragastric bacteria damage the gastric mucosa, reducing its resistance to acid, while epidemiological studies have suggested that a non-physiological factor, such as bacterial infection, is involved in the development of peptic ulcer. Subsequently, H. pylori, associated with chronic gastritis, was identified in gastric biopsies from patients with peptic ulcer. Eradication of H. pylori has been shown to reduce the recurrence of peptic ulcer after ulcer healing, and such treatment is now widely accepted.","PeriodicalId":21517,"journal":{"name":"Scandinavian journal of gastroenterology. Supplement","volume":"19 1","pages":"2-4; discussion 9-12"},"PeriodicalIF":0.0,"publicationDate":"2009-07-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90861851","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Abstracts from the XL Nordic Meeting of Gastroenterology, June 8-11, 2009, Stavanger, Norway.","authors":"","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":21517,"journal":{"name":"Scandinavian journal of gastroenterology. Supplement","volume":" 246","pages":"23-60"},"PeriodicalIF":0.0,"publicationDate":"2009-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"28406533","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Abstracts of the 39th Nordic Meeting of Gastroenterology, 30th Nordic Meeting of Digestive Endoscopy, 18th Nordic Meeting of Gastrointestinal Motility, and the Annual Endoscopy/Gastroenterology Nurses'/Assistants' Meeting Post-graduate course, 4-6 June 2008, Helsinki, Finland.","authors":"","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":21517,"journal":{"name":"Scandinavian journal of gastroenterology. Supplement","volume":" 245","pages":"20-51"},"PeriodicalIF":0.0,"publicationDate":"2008-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"27808411","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Abstracts from the XXXVIII Nordic Meeting of Gastroenterology, XXIX Nordic Meeting of Digestive Endoscopy, XVII Nordic Meeting of Gastrointestinal Motility, 6-9 June 2007, Reykjavik, Iceland.","authors":"","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":21517,"journal":{"name":"Scandinavian journal of gastroenterology. Supplement","volume":" 244","pages":"12-30"},"PeriodicalIF":0.0,"publicationDate":"2007-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"26968002","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Recent developments in gastrointestinal motility.","authors":"Andre J P M Smout","doi":"10.1080/00365520600664235","DOIUrl":"https://doi.org/10.1080/00365520600664235","url":null,"abstract":"<p><p>In the past decade, the results of many studies on gastrointestinal motility and perception have been published that may be relevant to the clinician. A new classification of oesophageal motor disorders has been proposed in which \"ineffective oesophageal motility\" largely replaces the former \"non-specific oesophageal motor disorders\". Recent studies have shown that the incidence of transient lower oesophageal sphincter relaxations can be reduced pharmacologically, and this may open doors to a new therapeutic approach in gastro-oesophageal reflux disease. The mechanisms through which hiatus hernia promotes reflux have become clearer. The recently developed technique of intraluminal impedance monitoring has made it possible to study oesophageal transit, non-acid reflux and its role in the generation of reflux symptoms, as well as the characteristics of belching. Measurement of gastric emptying by means of a non-radioactive isotope and breath-testing has become widely available but, unfortunately, this development has not yet been accompanied by the advent of new therapeutic options for gastroparesis. The term \"enteric dysmotility\" has been coined for the condition in which upper abdominal symptoms are associated with distinct small intestinal bowel motility disorders in the absence of ileus-like episodes. The role of high-amplitude propagated contractions in the pathogenesis of constipation has been further defined. In cases of suspected sphincter of Oddi dysfunction, manometry of both sphincters (IBD and pancreatic) is now felt to be advisable.</p>","PeriodicalId":21517,"journal":{"name":"Scandinavian journal of gastroenterology. Supplement","volume":" 243","pages":"25-31"},"PeriodicalIF":0.0,"publicationDate":"2006-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/00365520600664235","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"26095423","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The 19th and 20th highlights of gastroenterology and hepatology.","authors":"","doi":"10.1080/00365520600664185","DOIUrl":"https://doi.org/10.1080/00365520600664185","url":null,"abstract":"","PeriodicalId":21517,"journal":{"name":"Scandinavian journal of gastroenterology. Supplement","volume":" 243","pages":"1-178"},"PeriodicalIF":0.0,"publicationDate":"2006-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/00365520600664185","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"26096544","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Gastro-oesophageal reflux disease--experience in daily practice: symptoms and symptom assessment.","authors":"R J L F Loffeld","doi":"10.1080/00365520600664193","DOIUrl":"https://doi.org/10.1080/00365520600664193","url":null,"abstract":"<p><p>Gastro-oesophageal reflux disease is one of the most common medical problems in daily practice, with many guidelines on diagnosis and treatment available. The prevalence and incidence of reflux disease are rising. In a period of 10 years, the incidence of reflux oesophagitis has almost doubled, as has the number of pills and tablets of acid-suppressive therapy sold. The decreased number of patients with severe reflux oesophagitis is indicative of increased public awareness. Heartburn and regurgitation are the hallmarks of reflux disease. The symptom score in patients with the mild reflux oesophagitis is significantly higher than it is in patients presenting with severe oesophagitis, NERD or Barrett's oesophagus. Patients with mild oesophagitis also suffer from more reflux. Dysphagia is often the only presenting symptom in severe oesophagitis. Patients with reflux oesophagitis have a significantly higher symptom score than patients with Barrett's oesophagus. The scores for heartburn and acid regurgitation are significantly higher in reflux oesophagitis. The primary goal of treatment is complete clinical remission and prevention of long-term complications. In a study with a follow-up of 4.5 to 7.5 years in patients with reflux oesophagitis it was shown that 85% still used acid-suppressive therapy, mostly on a daily basis. However, the majority were never completely free of reflux. Despite the fact that the degree of reflux oesophagitis correlates with the risk of relapse, also patients in whom initially the most severe grade of reflux oesophagitis (grades III and IV) was diagnosed no longer use medication. Treatment of reflux disease with acid suppressants is a major component in national and international drug budgets, and health-care authorities and insurance companies are eager to reduce these budgets. Since diagnosis and treatment are already discussed in many guidelines, cut-backs could be achieved in patients on maintenance therapy. For this reason, more data have to be assessed on therapy outcome in cases of chronic maintenance therapy. Guidelines for maintenance or on-demand therapy are necessary.</p>","PeriodicalId":21517,"journal":{"name":"Scandinavian journal of gastroenterology. Supplement","volume":" 243","pages":"3-6"},"PeriodicalIF":0.0,"publicationDate":"2006-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/00365520600664193","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"26096545","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Intestinal transplantation in The Netherlands: first experience and future perspectives.","authors":"G Dijkstra,&nbsp;E H H M Rings,&nbsp;C M A Bijleveld,&nbsp;H M Van Dullemen,&nbsp;H S Hofker,&nbsp;R J Porte,&nbsp;R J Ploeg","doi":"10.1080/00365520600664243","DOIUrl":"https://doi.org/10.1080/00365520600664243","url":null,"abstract":"<p><p>Intestinal transplantation for intestinal failure is no longer an experimental procedure, but an accepted treatment for patients who fail total parenteral nutrition (TPN) therapy. Early referral for evaluation for small bowel transplantation has to be considered in patients with permanent intestinal failure who have occlusion of more than two major veins, frequent line-related septic episodes, impairment of liver function or an unacceptable quality of life. With the increased experience in post-transplant patient care and newer forms of induction (thymoglobulin, IL-2 receptor antagonists) and maintenance (tacrolimus) therapies the 1-year graft survival has increased to 65% for isolated and to 59% for liver/small bowel transplantation, and is further improving. Rejection, bacterial, fungal and viral (CMV, EBV) infection, post-transplant lymphoproliferative disease (PTLD) and graft versus host disease (GvHD) are the most common complications after intestinal transplantation. Although most of the long-term survivors are TPN-independent and have a good quality of life, the risk of the procedure and long-term adverse effects of immunosuppressive medication limits small bowel, or liver/small bowel transplantation only to patients with severe complications of TPN therapy.</p>","PeriodicalId":21517,"journal":{"name":"Scandinavian journal of gastroenterology. Supplement","volume":" 243","pages":"39-45"},"PeriodicalIF":0.0,"publicationDate":"2006-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/00365520600664243","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"26095425","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Autoimmune pancreatocholangitis: a series of ten patients.","authors":"Henk R van Buuren,&nbsp;Frank P Vleggaar,&nbsp;G Willemien Erkelens,&nbsp;Pieter E Zondervan,&nbsp;Wilco Lesterhuis,&nbsp;Casper H J Van Eijck,&nbsp;Julien B C M Puylaert,&nbsp;Sjoerd D J Van Der Werf","doi":"10.1080/00365520600664326","DOIUrl":"https://doi.org/10.1080/00365520600664326","url":null,"abstract":"<p><strong>Background: </strong>During a 10-year period we observed 10 patients who suffered from an inflammatory-fibrosing disease mimicking pancreatic carcinoma and primary sclerosing cholangitis (PSC).</p><p><strong>Methods: </strong>A review of the presenting features, the clinical course and the relevant literature.</p><p><strong>Results: </strong>Ten male patients (mean age 55 years) presented with weight loss, jaundice and pruritus. Pancreatic cancer was suggested by imaging studies, which showed focal or generalized pancreatic enlargement and compression of the distal common bile duct. Cholangiography also demonstrated intrahepatic biliary stenoses consistent with sclerosing cholangitis. None had evidence of IBD. Exocrine pancreatic insufficiency was found in six cases and diabetes in four. Pancreatic histology (n=3) showed fibrosis and extensive inflammatory infiltrates. Immunosuppressive treatment was instituted in five patients. Clinical and biochemical remission occurred in three; in one other patient, previously documented intrahepatic biliary strictures had disappeared after 3 months. One patient had concomitant Sjögren's disease. The clinical features, pancreatic involvement, age at presentation, absence of IBD and response to steroids all plead against a diagnosis of \"classical\" PSC. The natural course of the disease was highly variable. Thirty-five comparable cases, with a largest series of three, have been reported in the literature. The disease has been associated with Sjögren's disease, retroperitoneal fibrosis and other fibrosing conditions, and may be a manifestation of a systemic fibro-inflammatory disorder.</p><p><strong>Conclusion: </strong>Autoimmune pancreatocholangitis is a distinct inflammatory disorder involving the pancreas and biliary tree. The disease may mimick pancreatic carcinoma and PSC and responds to immunosuppressives.</p>","PeriodicalId":21517,"journal":{"name":"Scandinavian journal of gastroenterology. Supplement","volume":" 243","pages":"70-8"},"PeriodicalIF":0.0,"publicationDate":"2006-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/00365520600664326","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"26095429","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}